speb/financial-data huggingface dataset:
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Payables: 356710000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Payables: 356710000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 0.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 0.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Pretax Income: -151932000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Pretax Income: -152966000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
LYPSAGEMS.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 3701000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 3701000.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 162711000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 65147000.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 2146000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 520000.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 0.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -129933000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -129933000.00
LYPSAGEMS.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 0.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1247000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Share Issued: 29484000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 29484000.00
LYPSAGEMS.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 68400000.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
LYPSAGEMS.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: -749000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 164907000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 164907000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 164907000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 164907000.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Tax Provision: -185000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -185000.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 0.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Total Assets: 654945000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 654945000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 164907000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 164907000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Total Debt: 129758000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 129758000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 164907000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 164907000.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Total Expenses: 318808000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 218740000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 490038000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 490038000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 27728000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 27728000.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3201000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3201000.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Work In Process: 0.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2025-03-31) — Working Capital: 140380000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 140380000.00
LYPSAGEMS.NS income_statement (annual, 2025-03-31) — Write Off: 152476000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 781000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 11504000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 23900000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.01
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 10484000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 526000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 526000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 23900000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.01
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — EBIT: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — EBITDA: 765000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1020000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Net Income: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 765000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Operating Income: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 11504000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 213000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 239000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 10484000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 526000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 11265000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1149000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 46390000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 29351163.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.43
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 44524000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 532000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 532000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 29351163.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.43
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 12621000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — EBIT: 12621000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 13153000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1866000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Net Income: 12621000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 12621000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 12621000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 12621000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 12621000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 12621000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 13153000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 12621000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Operating Income: 717000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 46390000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 11904000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 289000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 12621000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 44524000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 532000.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 45673000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 3686000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 766000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 147238000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 17668000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 351921000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 351921000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 625822000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 625822000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 29338983.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 28883333.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Basic EPS: 0.59
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.12
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 4472000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 294840000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 294840000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 12000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 12000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4596000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4596000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -9315000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -392000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -71000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Change In Payable: -82000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -25344000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -35204000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 124000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 294840000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 294840000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 181698000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 181698000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 0.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 0.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 138751000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 14043000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 663160000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 663160000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Current Debt: 143471000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 143471000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 143471000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 143471000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 500605000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 500605000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 366000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 366000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Deferred Tax: 208000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Depreciation: 2091000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 2091000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 2091000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 501000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 2091000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 501000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 29338983.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 28883333.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Diluted EPS: 0.59
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.12
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 17310000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 3466000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — EBIT: 17105000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — EBIT: 3259000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — EBITDA: 19196000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 3760000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 4596000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 13713000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -16589000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -267000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 0.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 22136000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 22136000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Gross Profit: 8487000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 3625000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Interest Expense: 3000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 1000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 3000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Inventory: 31582000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 31582000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 325169000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 325169000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 3000000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 0.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 0.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 13713000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Net Debt: 143459000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 143459000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Net Income: 17310000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Net Income: 3466000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 17310000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 3466000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 17310000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3466000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 17310000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3466000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 17310000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3466000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 17102000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 17310000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3466000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Net Interest Income: -3000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -1000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 13713000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -3000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Net PPE: 22136000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 22136000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 3000000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 13713000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 181698000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 181698000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2993000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2993000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 19196000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 3760000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Normalized Income: 17310000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 3466000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -16589000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Operating Income: 4801000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Operating Income: 2859000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Operating Revenue: 147238000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 17668000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 29484000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 29484000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 1160000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1160000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: -113142000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -113142000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -519000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 12304000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 400000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 761000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Other Properties: 22136000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 22136000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 4584000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 4584000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Payables: 351921000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Payables: 351921000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Pretax Income: 17102000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 3258000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 0.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 138751000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 14043000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 2091000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 501000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 3000000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Share Issued: 29484000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 29484000.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 13713000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
LYPSAGEMS.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 181698000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 181698000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 181698000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 181698000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Tax Provision: -208000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -208000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 0.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Total Assets: 685296000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 685296000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 181698000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 181698000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Total Debt: 143471000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 143471000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 181698000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 181698000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Total Expenses: 142437000.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 14809000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 503598000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 503598000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 22136000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 22136000.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2993000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2993000.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
LYPSAGEMS.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
LYPSAGEMS.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
LYPSAGEMS.NS balance_sheet (annual, 2026-03-31) — Working Capital: 162555000.00
LYPSAGEMS.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 162555000.00
LYTIX.OL income_statement (annual, 2021-12-31) — Basic Average Shares: 33351859.00
LYTIX.OL income_statement (annual, 2021-12-31) — Basic EPS: -1.44
LYTIX.OL balance_sheet (annual, 2021-12-31) — Cash Equivalents: 1411000.00
LYTIX.OL income_statement (annual, 2021-12-31) — Diluted Average Shares: 33351859.00
LYTIX.OL income_statement (annual, 2021-12-31) — Diluted EPS: -1.44
LYTIX.OL balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 0.00
LYTIX.OL cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -423000.00
LYTIX.OL cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 0.00
LYTIX.OL cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -423000.00
LYTIX.OL cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -423000.00
LYTIX.OL cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 1000.00
LYTIX.OL cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
LYTIX.OL balance_sheet (annual, 2021-12-31) — Other Current Assets: -1000.00
LYTIX.OL cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: 0.00
LYTIX.OL cash_flow (annual, 2021-12-31) — Repayment Of Debt: -423000.00
LYTIX.OL income_statement (annual, 2022-12-31) — +Operating Expense: 76696000.00
LYTIX.OL income_statement (annual, 2022-12-31) — +Total Revenue: 11031000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Accounts Payable: 6997000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Accounts Receivable: 0.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1372000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 131027000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Basic Average Shares: 39855572.00
LYTIX.OL income_statement (annual, 2022-12-31) — Basic EPS: -1.40
LYTIX.OL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 197282000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 2593000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Capital Expenditure: -154000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1344000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Capital Stock: 4007000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 93179000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 143785000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Cash Equivalents: 1373000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Cash Financial: 93179000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Change In Payable: 3553000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Change In Receivables: -1055000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Change In Working Capital: 2498000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Changes In Cash: -102730000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Common Stock: 4007000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 135034000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Common Stock Issuance: 133000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Current Assets: 151893000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 868000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 868000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Current Liabilities: 17759000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Depreciation: 919000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 919000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 919000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Depreciation Income Statement: 919000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Diluted Average Shares: 39855572.00
LYTIX.OL income_statement (annual, 2022-12-31) — Diluted EPS: -1.40
LYTIX.OL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -56069000.00
LYTIX.OL income_statement (annual, 2022-12-31) — EBIT: -55923000.00
LYTIX.OL income_statement (annual, 2022-12-31) — EBITDA: -55004000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — End Cash Position: 94552000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Financing Cash Flow: -749000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Free Cash Flow: -52780000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 0.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Gross PPE: 2747000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Interest Expense: 146000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 146000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Interest Income: 1406000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1406000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Interest Paid Cff: -55000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Interest Received Cfi: 1406000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Invested Capital: 135034000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Investing Cash Flow: -49355000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 133000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 476000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 476000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -827000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 154000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 133000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Net Income: -56069000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -56069000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -56069000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -56069000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -56069000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -56069000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -56069000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -154000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Net Interest Income: 1875000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -50606000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -827000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -827000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 1875000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -1000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Net PPE: 1375000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -154000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 135034000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Normalized EBITDA: -55004000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Normalized Income: -56069000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Operating Cash Flow: -52626000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Operating Income: -65665000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Operating Revenue: 11031000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 40258082.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Other Non Cash Items: -1351000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Other Operating Expenses: 9843000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Other Payable: 6832000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Other Receivables: 5500000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 50606000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Payables: 14779000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Prepaid Assets: 737000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Pretax Income: -56069000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Properties: 0.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -154000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Purchase Of PPE: -154000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 919000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Repayment Of Debt: -827000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Research And Development: 45608000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Restricted Cash: 1373000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Share Issued: 40258082.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1376000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 135034000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Tangible Book Value: 135034000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
LYTIX.OL income_statement (annual, 2022-12-31) — Tax Provision: 0.00
LYTIX.OL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Taxes Receivable: 498000.00
LYTIX.OL cash_flow (annual, 2022-12-31) — Taxes Refund Paid: 0.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Total Assets: 153269000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Total Capitalization: 135034000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Total Debt: 1344000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 135034000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Total Expenses: 76696000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 18235000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1375000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 476000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -65666000.00
LYTIX.OL income_statement (annual, 2022-12-31) — Total Other Finance Cost: -615000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Total Tax Payable: 950000.00
LYTIX.OL balance_sheet (annual, 2022-12-31) — Working Capital: 134134000.00
LYTIX.OL income_statement (annual, 2023-12-31) — +Operating Expense: 100776000.00
LYTIX.OL income_statement (annual, 2023-12-31) — +Total Revenue: 3991000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Accounts Payable: 3572000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Accounts Receivable: 0.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -2334000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 47312000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Basic Average Shares: 40258082.00
LYTIX.OL income_statement (annual, 2023-12-31) — Basic EPS: -2.18
LYTIX.OL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 94552000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 2680000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Capital Expenditure: -49000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 492000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Capital Stock: 4007000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 25794000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 48977000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Cash Financial: 25794000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Change In Payable: -4828000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Change In Receivables: -6042000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Change In Working Capital: -10870000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Changes In Cash: -67187000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Common Stock: 4007000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Common Stock Equity: 51319000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Current Assets: 63326000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 451000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 451000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Current Liabilities: 12514000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Depreciation: 962000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 962000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 962000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Depreciation Income Statement: 962000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Diluted Average Shares: 40258082.00
LYTIX.OL income_statement (annual, 2023-12-31) — Diluted EPS: -2.18
LYTIX.OL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -87897000.00
LYTIX.OL income_statement (annual, 2023-12-31) — EBIT: -87841000.00
LYTIX.OL income_statement (annual, 2023-12-31) — EBITDA: -86879000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — End Cash Position: 27365000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Financing Cash Flow: -943000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Free Cash Flow: -96018000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Gross PPE: 2883000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Interest Expense: 56000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 56000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Interest Income: 2351000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Interest Income Non Operating: 2351000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Interest Paid Cff: -3000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Interest Received Cfi: 2351000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Invested Capital: 51319000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Investing Cash Flow: 29725000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 41000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 41000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -940000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 203000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
LYTIX.OL income_statement (annual, 2023-12-31) — Net Income: -87897000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -87897000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -87897000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -87897000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -87897000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -87897000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -87897000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Net Interest Income: 4879000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 27423000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -940000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -940000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 4879000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Net PPE: 549000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -49000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 51319000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Normalized EBITDA: -86879000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Normalized Income: -87897000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Operating Cash Flow: -95969000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Operating Income: -96785000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Operating Revenue: 3991000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 40258082.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Other Cash Adjustment Outside Changein Cash: -273000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Other Current Assets: 1000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Other Current Liabilities: -1000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Other Non Cash Items: -2348000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Other Non Current Assets: -1000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Other Operating Expenses: 12303000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Other Payable: 4745000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Other Receivables: 11768000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 23183000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Payables: 9681000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Prepaid Assets: 655000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Pretax Income: -87897000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Properties: 0.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Purchase Of PPE: -49000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 962000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Repayment Of Debt: -940000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Research And Development: 63167000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Restricted Cash: 1571000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Sale Of Investment: 27423000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Share Issued: 40258082.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Stock Based Compensation: 4183000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Stockholders Equity: 51319000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Tangible Book Value: 51319000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
LYTIX.OL income_statement (annual, 2023-12-31) — Tax Provision: 0.00
LYTIX.OL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Taxes Receivable: 354000.00
LYTIX.OL cash_flow (annual, 2023-12-31) — Taxes Refund Paid: 0.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Total Assets: 63874000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Total Capitalization: 51319000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Total Debt: 492000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 51319000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Total Expenses: 100776000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 12555000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 548000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 41000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -96785000.00
LYTIX.OL income_statement (annual, 2023-12-31) — Total Other Finance Cost: -2584000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Total Tax Payable: 1364000.00
LYTIX.OL balance_sheet (annual, 2023-12-31) — Working Capital: 50812000.00
LYTIX.OL balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1000.00
LYTIX.OL income_statement (annual, 2024-12-31) — +Operating Expense: 107030000.00
LYTIX.OL income_statement (annual, 2024-12-31) — +Total Revenue: 11133000.00
LYTIX.OL balance_sheet (annual, 2024-12-31) — Accounts Payable: 5015000.00
LYTIX.OL balance_sheet (annual, 2024-12-31) — Accounts Receivable: 458000.00
LYTIX.OL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -569000.00